N
UNCY icon

Nuveen’s Unicycive Therapeutics UNCY Stock Holding History

Nuveen’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
+47,820
New +$353K ﹤0.01% 3605

Other funds holding UNCY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Nuveen's UNCY Position: Q2 2026 in Review

Nuveen opened a new position in Unicycive Therapeutics (UNCY) in Q2 2026: 47,820 shares worth $224K. The stake represents ﹤0.01% of the portfolio and ranks #3605 among its holdings.

23 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Nuveen held 47,820 shares of Unicycive Therapeutics worth $224K as of Q2 2026.
  • Unicycive Therapeutics was a new Nuveen position in Q2 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3605 holding.
  • 23 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.